NW
Northwest Biotherapeutics, Inc.
NWBO · OTC
$0.16 +2.60% (+$0.00)
1M -7.99%
Market Cap $261.8M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 120.47x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 6.45%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 36.95%
Net margin 1,751.63%
Op. margin 2,316.11%
Quality
0 /100
Poor ROIC 136.63%
ROA 50.12%
Asset turnover 0.03x
Debt
0 /100
High Current ratio 0.04x
Int. coverage -6.81x
Debt/Equity N/A
Stability
48 /100
Moderate Beta -0.61x
Rev. volatility 21.96%
EPS volatility 30.94%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NWBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Linda F. Powers
Employees
105
Headquarters
Bethesda
Nadcházející události
12 LIS
Earnings
Upcoming earnings report